Gene · 344
Papers3,206
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,206
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasma proteomic and metabolomic signatures of B-ALL patients during CAR-T cell therapy. | Clin Transl Med | 2023 | 36938989 | PubTator, text mining | PubMed |
| Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial. | J Atheroscler Thromb | 2023 | 36908150 | PubTator, text mining | PubMed |
| Nutritional Treatment of Hypertriglyceridemia in Childhood: From Healthy-Heart Counselling to Life-Saving Diet. | Nutrients | 2023 | 36904088 | PubTator, text mining | PubMed |
| Plasma Apolipoprotein Concentrations Are Highly Altered in Severe Intensive Care Unit COVID-19 Patients: Preliminary Results from the LIPICOR Cohort Study. | Int J Mol Sci | 2023 | 36902035 | PubTator, text mining | PubMed |
| Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case-control study. | Diabetol Metab Syndr | 2023 | 36899434 | PubTator, text mining | PubMed |
| Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial. | Nat Med | 2023 | 36879129 | PubTator, text mining | PubMed |
| Long-Term Nutritional Counseling for a Patient with Lipoprotein Lipase Deficiency. | J Atheroscler Thromb | 2023 | 36878607 | PubTator, text mining | PubMed |
| A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines. | Cell Rep Med | 2023 | 36871558 | PubTator, text mining | PubMed |
| Serum-integrated omics reveal the host response landscape for severe pediatric community-acquired pneumonia. | Crit Care | 2023 | 36859478 | PubTator, text mining | PubMed |
| Fine particulate matter (PM2.5)-induced pulmonary oxidative stress contributes to changes in the plasma lipidome and liver transcriptome in mice. | Toxicol Sci | 2023 | 36857595 | PubTator, text mining | PubMed |
| Apolipoprotein C3 is negatively associated with estrogen and mediates the protective effect of estrogen on hypertriglyceridemia in obese adults. | Lipids Health Dis | 2023 | 36855114 | PubTator, text mining | PubMed |
| Measuring VLDL1 secretion in humans with an intravenous fat emulsion test. | STAR Protoc | 2023 | 36853686 | PubTator, text mining | PubMed |
| High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity. | Metabolites | 2023 | 36837872 | PubTator, text mining | PubMed |
| Alzheimer's Disease: An Updated Overview of Its Genetics. | Int J Mol Sci | 2023 | 36835161 | PubTator, text mining | PubMed |
| A Novel Blood Proteomic Signature for Prostate Cancer. | Cancers (Basel) | 2023 | 36831393 | PubTator, text mining | PubMed |
| Hepatitis C Virus-Lipid Interplay: Pathogenesis and Clinical Impact. | Biomedicines | 2023 | 36830808 | PubTator, text mining | PubMed |
Bioinformatic Analyses of Peripheral Blood Transcriptome Identify Altered Neutrophil-Related Pathway and Different Transcriptomic Profiles for Acute Pancreatitis in Patients with and without Chylomicronemia Syndrome. | Biomolecules | 2023 | 36830652 | PubTator, text mining | PubMed |
| Low-density lipoprotein: a versatile nanoscale platform for targeted delivery. | Nanoscale Adv | 2023 | 36798503 | PubTator, text mining | PubMed |
| Visualizing increased uptake of [18F]FDG and [18F]FTHA in kidneys from obese high-fat diet fed C57BL/6J mice using PET/CT ex vivo. | PLoS One | 2023 | 36787333 | PubTator, text mining | PubMed |
| Metabolomic, proteomic, and transcriptomic changes in adults with epilepsy on modified Atkins diet. | Epilepsia | 2023 | 36775798 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/344/papers?page=16